Skip to main content
. 2023 Dec 29;11(2):628–636. doi: 10.1002/ehf2.14647

Figure 4.

Figure 4

Treatment effect of vericiguat vs. placebo on the primary endpoint [heart failure (HF) hospitalization or cardiovascular (CV) death] by index admission event subgroup in the VICTORIA trial. CI, confidence interval; HR, hazard ratio. Source: Figure performed with data from references 42, 56.